Navigation Links
Xceed Molecular Names Fran Tuttle to Its Board of Trustees
Date:10/9/2007

WELLESLEY, Mass., Oct. 9 /PRNewswire/ -- Xceed Molecular Corporation, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced today that Fran Tuttle has been appointed to Xceed's board of directors. Ms. Tuttle is president and chief executive officer of HX Diagnostics, a California-based company focused on developing a point-of-care diagnostic for avian flu.

"Fran is the ideal complement to our board," said Xceed's President and CEO, David Deems. "She has more than 20 years of leadership in the diagnostics industry -- including significant experience with commercialization of novel technologies. Her knowledge, counsel, and close connections with thought leaders in the field will be invaluable to us as we continue to further develop our products and solutions for multiplexed gene-expression tests for clinical research today, and in vitro diagnostics tomorrow."

Prior to HX Diagnostics, Ms. Tuttle was president and chief executive officer of Protedyne Corporation (now part of LabCorp), which developed robotics for the molecular-diagnostic-testing industry. Previously, she was senior vice president of near patient testing at Bayer Diagnostics, one of the world's largest diagnostic companies. At Bayer, she was responsible for a worldwide business of $400 million. Before joining Bayer Diagnostics, she spent 20 years at Chiron Diagnostics (formerly Ciba Corning Diagnostics), a leader in molecular and immunodiagnostics. Ms. Tuttle began her career as a CPA at Peat, Marwick, Mitchell and Company (now KPMG). She holds a master's in business administration from Harvard Business School as well as bachelor's degrees in accounting from the University of North Carolina at Chapel Hill and German from Duke University.

About Xceed Molecular

Xceed's vision is to advance molecular diagnostics and improve health outcomes by providing a cost-effective, automated system and services that facilitate the rapid translation of novel multiplexed genomic tests from research into routine clinical use. We designed our proprietary system to perform multiplexed molecular assays with superior accuracy, reproducibility, speed, and scalability at significantly lower cost than conventional array- or PCR-based systems. Our offerings include: the Ziplex(TM) System for automated gene-expression analysis, comprising an automated workstation, TipChip consumable arrays, and reagents (available in the US and Canada for research use only); Signature Chips -- pre-configured arrays focusing on a number of specific disease targets; and custom array services. Xceed's R&D and manufacturing operations are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts. For more information, visit http://www.Xceedmolecular.com.


'/>"/>
SOURCE Xceed Molecular Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. AIDS toll set to exceed Black Death
2. America’s Demand For Organic Foods Far Exceeds the Suppl
3. Mercury Levels In Canned Tuna Exceed Guidelines
4. Cholesterol in Stroke Patients Exceeds National Guidelines
5. Dengue Deaths in Cambodia This Year Exceed 2006 Toll
6. Molecular markers for early diagnosis of breast and ovarian cancer
7. Scientists Developed Map For Brain Molecular Communities
8. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
9. Molecular Flaw Detected in Aggressive Breast Cancers
10. Molecular Computer Developed To perform Calculations From Within Human Body
11. Lung cancer molecular profile discovered by researchers.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... ... Amir Qureshi, MD is the first physician in Arkansas to implant Nuvecta’s Algovita® ... Algovita SCS System has been FDA approved as a treatment option for chronic intractable ... the most powerful SCS system and the only stretchable lead on the market. This ...
(Date:5/26/2017)... ... , ... On May 24, the Congressional Budget Office (CBO) projected that the ... 4, would result in 23 million Americans losing their health insurance by 2026 as ... and Affordable Care Act (ACA). , “It is clear from the CBO analysis ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing ... blog post on insurance options. If a Bay Area patient has to search for ... and money. Visiting an in-network provider for a second opinion can ensure a patient ...
(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and ... Odds” is the creation of published author, Walter Hubbard, a retired wildlife and fisheries ... child Jane. Walter. Walter and Jane have three adult children and a granddaughter. ...
(Date:5/24/2017)... ... 24, 2017 , ... Altec Products, Inc., a leader in enterprise ... one-day technology conference in San Diego, CA. , At nVerge 2017, Altec will ... utilize and enhance their Sage ERP solutions by providing improved visibility and control to ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... WAYNE, Pa. , May 4, 2017 /PRNewswire/ ... made from thermoplastics and other highly-engineered materials, is ... Microextrusion tubing has been developed in recent ... neurovascular interventional therapies and surgical applications. More expensive ... used to produce microextrusion tubing due to their ...
(Date:5/3/2017)... Calif. , May 3, 2017 ... of any hospital or healthcare facility. Commonly referred ... room is equipped with diagnostic imaging technology to ... of the heart. In these spaces, a team ... catheterization, balloon angioplasty, percutaneous coronary intervention, congenital heart ...
(Date:5/3/2017)... N.J. , May 3, 2017  Getinge, ... that contribute to quality enhancement and cost efficiency ... from a study of contemporary practice demonstrating that ... first-line therapy for critically ill patients. The single-center, ... Company,s newer large volume MEGA ® 50cc ...
Breaking Medicine Technology: